Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Crohn Disease (CD)
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Crohn Disease
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Jun 12, 2028
Moderately to Severely Active Crohns Disease
This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction t…
Glendale, United StatesEst. completion Dec 31, 2028
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis AcuteIBD (Inflammatory Bowel Disease)CD - Crohn's Disease
A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK…
Hangzhou, ChinaEst. completion Dec 31, 2026
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lin…
Harrow, United KingdomEst. completion Mar 5, 2029
Crohn Disease
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with mode…
Dothan, United StatesEst. completion Nov 15, 2028
Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tra…
Dothan, United StatesEst. completion Jan 2030
Crohn Disease
The purpose of this study is to evaluate how well guselkumab works in participants with Crohn's disease (CD; a long-term…
Guangzhou, ChinaEst. completion Sep 15, 2027
Crohn Disease
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in p…
Chandler, United StatesEst. completion Sep 19, 2028
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
Quiescent Crohn's Disease (CD)
Many individuals with Crohn's disease continue to experience abdominal pain, bloating, or bowel habit changes even when …
Ann Arbor, United StatesEst. completion Dec 2029
Crohn Disease (CD)Ileocolic ResectionPost-endoscopic Operative Reccurence
Crohn's disease (CD) (\> 200,000 patients in France) is a chronic inflammatory disease that can lead to progression of i…
Amiens, FranceEst. completion Mar 1, 2027
Crohn's Disease
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants wi…
Los Angeles, United StatesEst. completion Oct 27, 2027
Crohn Disease (CD)
The ADICROHN-3 study is a prospective, multicenter, open-label cohort study.
Its design is supported by the following e…
Marseille, FranceEst. completion Jun 29, 2028
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated …
Berlin, GermanyEst. completion Jan 15, 2029
Crohn Disease (CD)
The purpose of this research study is to evaluate what type of treatment will be beneficial for people with Crohn's dise…
Beverly Hills, United StatesEst. completion May 2028
Crohn Disease
The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089)…
Scottsdale, United StatesEst. completion Jun 2027
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027